Pfizer will list its COVID-19 treatment Paxlovid at a price of $1,390 per five-day course when it soon hits the commercial market, the drugmaker confirmed to Axios.
Why it matters: Paxlovid’s new listed price, first reported by the Wall Street Journal, will be more than twice the $529 paid by the federal government, which until now has maintained the entire U.S. supply of the key antiviral medication.
I did not pay a cent. Got 3 shots.
you pay taxes though, do you not?
Yeah. I forgot that I live not in US.
If the government paid, you paid through taxes, you just didn’t pay at the counter when you got them.
Just like nationalized healthcare.